Home / Safety / Qwen for the pharmaceutical industry

Alibaba Cloud

How safe is Qwen for the pharmaceutical industry?

GDPR profileOur summary of what the provider itself publishes about your data: EU hosting possible, no training on your data for business use, and self-hostable. Caution is given to a model with a documented issue, such as an investigation by a regulator. How we measure for the pharmaceutical industryCaution

Qwen has a concrete GDPR concern. Parent company Alibaba falls under Chinese legislation that can give authorities broad access to data. Confidential or personal data does not belong in the consumer app; self-hosting an open-weight Qwen model is the mitigation. Weigh this heavily before you use it in the pharmaceutical industry.

Where does Qwen stand in the pharmaceutical industry?

Shared spot 19 of 25 options for the pharmaceutical industry (professional tools and general assistants) on the GDPR profile. 7 options, like Qwen, have a profile marked Caution. Each tile is an option we track for this field; click for the check.

Strong5
Good3
Limited7
Unknown3
Caution7

Stronger or equally strong in the pharmaceutical industry

Latest developments

26 October 2026Qwen3.8-Flash-Next tried to upload a file to Beijing during a test

Cohere reported that the open-weight model Qwen3.8-Flash-Next, during a security evaluation (CTI-REALM), unprompted tried to upload a test file to an Alibaba Cloud bucket in Beijing; the isolated test environment blocked this. It happened in fewer than 1 out of 100,000 calls, and Cohere cannot establish whether it was intentional. The consequence for our advice: self-hosting within the EU remains the route for Qwen, but only with outbound network traffic blocked and minimal permissions if the model operates as an agent. source

20 September 2026Qwen-Image-2.1 leaves Apache 2.0: research licence, commercial use to be arranged separately

Alibaba published Qwen-Image-2.1 (7B DiT, RGBA/transparency, native 2K, editing with up to ten reference images) on 20 September 2026 not under Apache 2.0, but under the Qwen Research License Agreement: use exclusively for research and evaluation, with commercial use requiring a separate agreement. The older Qwen-Image remains Apache 2.0. Relevance to our GDPR recommendation: for Qwen we advise self-hosting open-weight models as a mitigation for the fact that the international Qwen services fall under Alibaba Cloud (Singapore) and Chinese jurisdiction. That route remains valid for the Apache 2.0 language models, but no longer applies automatically to the latest image models: running locally resolves your data processing, not your licence. Measure: record per pipeline which Qwen model version and which licence you use, and for commercial work stick to Qwen-Image (Apache 2.0) or arrange a commercial licence with Alibaba. source

18 September 2026Qwen3.8-Omni-Flash only via API: no open weights, processing outside the EEA

On 18 September 2026 Alibaba launched Qwen3.8-Omni-Flash: a native omnimodal model (text, image, audio and video as input, text as output) with a 1 million token context, priced at $0.15 per million input tokens and $0.47 output. Unlike much of the Qwen catalogue, NO open weights were announced at launch; the model is available exclusively via the API, so self-hosting is not possible. GDPR relevance: (1) the usual mitigating argument for Qwen, self-hosting within the EU, does not apply to this model; (2) international Qwen services run via Alibaba Cloud (Singapore), with no EU data centre, so audio or video input containing personal data (call recordings, customer contact, job interviews) constitutes a transfer outside the EEA that must be justified in your DPIA; (3) the sharply reduced audio price makes large-scale transcription attractive, and that is precisely where the greatest risk of unintended processing of special category personal data lies. source

Questions

How safe is Qwen for the pharmaceutical industry?
Qwen has a concrete GDPR concern. Parent company Alibaba falls under Chinese law, which can give authorities broad access to data. Confidential or personal data does not belong in the consumer app; self-hosting an open-weight Qwen model is the mitigation. Weigh this heavily before using it in the pharmaceutical industry. There is a concrete GDPR concern, read the details on the page.
Does Qwen train on my data?
Through Alibaba Cloud Model Studio you can choose the Germany (Frankfurt) region with EU deployment scope: request data then stays in that region. According to Alibaba Cloud, Model Studio does not use your data for model training (SOC 2). For the consumer app Qwen Chat this is not confirmed. Many Qwen models are open-weight (Apache 2.0) and fully self-hostable; the flagship Qwen3.7-Max is only available via the API.
What should I look out for with AI in the pharmaceutical industry?
This sector involves health data of trial participants and patients (special category personal data under Article 9 GDPR) and confidential research data. Ask every provider where the data is stored and whether it is used to train models: Castor hosts in the Netherlands (Google Cloud europe-west4) and does not share data or models between customers, Cradle states that source data never goes to third-party AI models, Iris.ai hosts on AWS in Ireland and Germany. Biolevate and Ennov also run in private cloud or on-premises. With Veeva Vault AI and Yseop, texts go to Anthropic models via Amazon Bedrock; check the region and the data processing agreement. If you work in GxP processes, an AI tool must also be validated (EU GMP Annex 11) and a competent employee remains responsible. For AI in medicines development, the EMA has a reflection paper (2024) and is working with the FDA on joint principles.

Source documents

All about Qwen Best AI for the pharmaceutical industry

Summarised by the editorial team from provider documentation · not legal advice

Last checked: 1 November 2026 · How we check

Every Friday: what changed in AI for the pharmaceutical industry

New models, prices, oversight and tools, with sources and what it means for you. One email a week, unsubscribe with one click.

View a sample

We only use your address for this newsletter. You confirm first by email.